Tumour blood flow changes induced by application of electric pulses

European Journal of Cancer

Volumn 35, Issue 4, 1999, Pages 672-677

  Sersa G ^a   Cemazar M ^a   Parkins, C S ^b   Chaplin, D J ^b  

^a INSTITUTE OF ONCOLOGY   (Slovenia)

^b MOUNT VERNON HOSPITAL   (United Kingdom)

Author keywords

86RbCl; Blood flow; Electric pulses; SA 1 mouse fibrosarcoma

Indexed keywords

RUBIDIUM CHLORIDE RB 86;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; ELECTROSTIMULATION THERAPY; FEMALE; FIBROSARCOMA; HYPOXIA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SOLID TUMOR; TUMOR BLOOD FLOW; TUMOR VOLUME;

ANIMALS; BLOOD FLOW VELOCITY; CELL DIVISION; ELECTRIC STIMULATION; FEMALE; FIBROSARCOMA; MALE; MICE; MICE, INBRED A; NEOPLASMS; TIME FACTORS;

EID: 0033119074     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(98)00426-2     Document Type: Article

References (36)

1. Brown JM. Exploitation of bioreductive agents with vasoactive drugs. In Fiedlen EM, Fowler JF, Hendry JH, Scott D, eds. Proceedings of the Eighth International Congress on Radiation Research, Edinburgh UK, Vol. 2. London, Taylor and Francis, 1987, 719-724.
2. Chaplin D.J., Acker B. The effect of hydralazine on the tumor cytotoxicity of the hypoxic cell cytotoxin RSU-1069: evidence for therapeutic gain. Int. J. Radiat. Oncol. Biol. Phys. 13:1987;579-585.
3. Stratford I.J., Adams G.E., Godden J., Nolan J., Howells N., Timpson N. Potentiation of the anti-tumour effect of melphalan by the vasoactive agent, hydralazine. Br. J. Cancer. 58:1988;122-127.
4. Denekamp J., Hill S.A., Hobson B. Vascular occlusion and tumour cell death. Eur. J. Cancer Clin. Oncol. 19:1983;271-275.
5. Chaplin D.J., Horsman M.R. The influence of tumor temperature on ischemia-induced cell death: potential implications for the evaluation of vascular mediated therapies. Radiother. Oncol. 30:1994;59-65.
6. Song C.W. Effect of local hyperthermia on blood flow and microenvironment. Cancer Res. 44:1984;4721-4730.
7. Fingar V.H., Henderson B.W. Drug and light dose dependence of photodynamic therapy: a study of tumour and normal tissue response. Photochem. Photobiol. 46:1987;837-841.
8. Gamarra F., Spelsberg F., Kuhnle G.E.H., Goetz A.E. High-energy shock waves induce blood flow reduction in tumors. Cancer Res. 53:1993;1590-1595.
9. Naredi P.L.J., Lindner P.G., Holmberg S.B., Stenram U., Peterson A., Hafström L.R. The effects of tumour necrosis factor alpha on the vascular bed and blood flow in an experimental rat hepatoma. Int. J. Cancer. 54:1993;645-649.
10. Kallinowski F., Schaefer C., Tyler G., Vaupel P. In vivo targets of recombinant human tumor necrosis factor-a: blood flow, oxygen consumption and growth of isotransplanted rat tumours. Br. J. Cancer. 60:1989;555-560.
11. Braunschweiger P.G., Johnson C.S., Kumar N., Ord V., Furmonski P. Antitumor effects of recombinant human interleukin 1α in RIF-1 and PancO2 solid tumours. Cancer Res. 48:1988;6011-6016.
12. Chaplin D.J. The effect of therapy on tumor vascular function. Int. J. Radiat. Biol. 60:1991;311-325.
13. Hill S.A., Sampson L.E., Chaplin D.J. Anti-vascular approaches to solid tumour therapy: evaluation of vinblastine and flavone acetic acid. Int. J. Cancer. 63:1995;119-123.
14. Mir L.M., Orlowski S., Belehradek Jr J., et al. Biomedical application of electric pulses with special emphasis on antitumor electrochemotherapy. Bioelectroch. Bioener. 38:1995;203-207.
15. Heller R., Jaroszeski M.J., Atkin D., et al. In vivo gene electroinjection and expression in rat liver. FEBS Lett. 389:1996;225-228.
16. Mir L.M., Orlowski S., Belehradek Jr J., Paoletti C. Electrochemotherapy potentiation of antitumour effect of bleomycin by local electric pulses. Eur. J. Cancer. 27:1991;68-72.
17. Serša G., Čemažar M., Miklavčič D. Antitumor effectiveness of electrochemotherapy with cis-diamminedichloroplatinum(II) in mice. Cancer Res. 55:1995;3450-3455.
18. Mir L.M., Glass L.F., Serša G., et al. Effective treatment of cutaneous and subcutaneous malignant tumors by electrochemotherapy. Br. J. Cancer. 77:1998;2336-2342.
19. Salford L.G., Persson B.R., Brun A., Ceberg P.C., Kongstad P.C., Mir L.M. A new brain tumour therapy combining bleomycin with in vivo electropermeabilization. Biochem. Bioph. Res. Co. 194:1993;938-943.
20. Heller R., Jaroszeski M., Leo-Messina J., et al. Treatment of B16 mouse melanoma with the combination of electropermeabilization and chemotherapy. Bioelectroch. Bioener. 36:1995;83-87.
21. Heller R., Jaroszeski M.J., Glass L.F., et al. Phase I/II trial for the treatment of cutaneous and subcutaneous tumors using electrochemotherapy. Cancer. 77:1996;964-971.
22. Serša G., Čemažar M., Miklavčič D., Mir L.M. Electrochemotherapy: variable anti-tumor effect on different tumor models. Bioelectroch. Bioener. 35:1994;23-27.
23. Serša G., Štabuc B., Čemažar M., Jančar B., Miklavčič D., Rudolf Z. Electrochemotherapy with cisplatin: potentiation of local cisplatin antitumor effectiveness by application of electric pulses in cancer patients. Eur. J. Cancer. 34:1998;1213-1218.
24. Domenge C., Orlowski S., Luboinski B., et al. Antitumor electrochemotherapy. New advances in the clinical protocol. Cancer. 77:1996;956-963.
25. Rudolf Z., Štabuc B., Čemažar M., Miklavčič D., Vodovnik L., Serša G. Electrochemotherapy with bleomycin: the first clinical experience in malignant melanoma patients. Radiol. Oncol. 29:1995;229-235.
26. Orlowski S., Mir L.M. Cell electropermeabilization: a new tool for biochemical and pharmacological studies. Biochim. Biophys. Acta. 1154:1993;51-63.
27. Serša G., Čemažar M., Miklavčič D. Changing electrode orientation improves the efficacy of electrochemotherapy of solid tumors in mice. Bioelectroch. Bioener. 39:1996;61-66.
28. Sapirstein L.A. Regional blood flow by fractional distribution of indicators. Am. J. Physiol. 193:1958;161-168.
29. Hill S.A., Denekamp J. Site dependent response of tumours to combined heat and radiation. Br. J. Radiol. 55:1982;905-912.
30. Horsman M.R., Christensen K.L., Overgaard J. Relationship between the hydralazine-induced changes in murine tumor blood supply and mouse blood pressure. Int. J. Radiat. Oncol. Biol. Phys. 22:1992;455-458.
31. Parkins C.S., Denekamp J., Chaplin D.J. Enhancement of mitomycin-C by combination with flavone acetic acid in a murine tumour. Anticancer Res. 13:1993;1437-1442.
32. Heller R., Jaroszeski M.J., Perrot R., Messina J.L., Gilbert R.A. Effective treatment of B16 melanoma by direct delivery of bleomycin using electrochemotherapy. Melanoma Res. 7:1997;10-18.
33. Neumann E, Sowers AE , Jordan CA. Electroporation and Electrofusion in Cell Biology. New York, Plenum Press, 1989.
34. Sauer H., Hescheler J., Reis D., Diedershagen H., Niedermeier S., Wartenberg M. DC electrical field-induced c-fos expression and growth stimulation in multicellular prostate cancer spheroids. Br. J. Cancer. 75:1997;1481-1488.
35. Jaroszeski M.J., Gilbert R.A., Heller R. In vivo antitumor effect of electrochemotherapy in hepatoma model. Biochim. Biophys. Acta. 1334:1997;15-18.
36. Mir L.M., Devauchelle P., Quintin-Colonna F., et al. First clinical trial of electrochemotherapy for the treatment of cat soft tissue sarcomas. Br. J. Cancer. 76:1997;1617-1622.